Perlin Pharmaceuticals Private Limited
Perlin Pharmaceuticals Private Limited is a Private Non-govt company company incorporated in 2019 and based in Telangana, India. It was founded by Suryaprabha and Akondi. Perlin Pharmaceuticals Private Limited operates in Pharmaceuticals & Chemicals (NIC 24290) with authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L. For 2022-23, the company reported revenue of ₹0 and a net loss of ₹30.3K. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Explore the complete profile of PERLIN PHARMACEUTICALS PRIVATE LIMITED, including financials and company filings, contact details, and much more on Tracxn.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Perlin Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +27d | filed |
| MGT-7 | FY2024-25 | 23 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 27 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +13d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Perlin Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 197624393 | ICICI Bank Ltd(Bank) | ₹20.74 Cr | 04 Jul 2020 | Open |
| 883137028 | ICICI Bank Ltd(Bank) | ₹18.15 Cr | 19 Sep 2022 | Open |
| 741757154 | HDFC Bank Ltd(Bank) | ₹23.59 Cr | 04 Jul 2021 | Satisfied |
| 254974223 | HDFC Bank Ltd(Bank) | ₹22.96 Cr | 12 Mar 2022 | Open |
Charge IDs, lenders & amounts for Perlin Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2022-23 | — | ||||
| 2019-20 | — |
Detailed Financials
2 FYs| Line item | 2022-23 | 2019-20 |
|---|---|---|
| Income statement | ||
| Revenue from operations | ||
| Other income | ||
| Total income | ||
| Total expenses | ||
| Profit before tax | ||
| Profit / (Loss) after tax | ||
| Balance sheet | ||
| Equity / Net worth | ||
| Borrowings | ||
| Current liabilities | ||
| Total liabilities | ||
| Current assets | ||
| Cash & equivalents | ||
| Total assets | ||
| Employees | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2022-23 | — | — | — | |
| Profit after Tax2022-23 | — | — | — | |
| Net Worth2022-23 | -70.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2019-20 | — | — | -21.54% | -12.23% | 1.76 | |||
| 2022-23 | — | — | -599.72% | -27.34% | 21.93 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 1,08,52,202 | 77.46% |
| Institutional Investors | 3 | 14,09,994 | 10.06% |
| Public & Others | 5 | 17,47,084 | 12.47% |
Promoter, institutional & public holding for Perlin Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
313 peersEvents & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.